Halladay Benjamin 4
4 · Esperion Therapeutics, Inc. · Filed Mar 15, 2023
Insider Transaction Report
Form 4
Halladay Benjamin
Chief Financial Officer
Transactions
- Award
Common Stock
2023-03-14+9,200→ 73,936 total - Award
Stock Option (right to buy)
2023-03-14+39,000→ 39,000 totalExercise: $4.02Exp: 2033-03-14→ Common Stock (39,000 underlying)
Footnotes (3)
- [F1]Such award will vest over a four (4) year period in equal quarterly installments, the first of which shall be on June 15, 2023, subject to continued service.
- [F2]Consists of 73,936 shares of common stock held, including 2,306 shares recently acquired in Esperion's Employee Stock Purchase Plan.
- [F3]Such options will vest over a four (4) year period in equal quarterly installments, the first of which shall be on June 15, 2023, subject to continued service.